BioChat's webinar series continues with Yurogen's Hao Cheng, PhD, our Chief Scientific Officer! This time, Dr. Cheng leads us through the philosophy and science behind antibody engineering, the applications of antibody engineering to create better research tools and therapeutics, and the future innovations we may see with both Yurogen's technology and biomedical research as a whole. From small antibody fragments to bispecific antibodies to camelid nanobodies, the sky is the limit for Yurogen's antibody engineering team!
Please also check out Dr. Beaker's page, which includes information on our BioChat podcast, as well as our blogs where we hope we can inspire you in new research directions!